13C MRS studies of neuroenergetics and neurotransmitter cycling in humans

NMR in Biomedicine

Volumn 24, Issue 8, 2011, Pages 943-957

  Rothman, Douglas L ^a,b   de Feyter, Henk M ^a   de Graaf, Robin A ^a,b   Mason, Graeme F ^a   Behar, Kevin L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

13C; Brain; Human; Metabolism; MRS; Neuroenergetics; Neurotransmitter cycling

Indexed keywords

13C; HUMAN; MRS; NEUROENERGETICS; NEUROTRANSMITTER CYCLING;

ANIMALS; METABOLISM; NONINVASIVE MEDICAL PROCEDURES; PHYSIOLOGY;

BRAIN;

3 HYDROXYBUTYRIC ACID; ACETIC ACID; AMMONIA; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; LACTIC ACID; NEUROTRANSMITTER; PYRUVATE CARBOXYLASE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CARBON; DIAGNOSTIC AGENT;

AGING; ALZHEIMER DISEASE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN DISEASE; BRAIN METABOLISM; BRAIN TUMOR; CARBON NUCLEAR MAGNETIC RESONANCE; DILUTION; ENERGY METABOLISM; ENERGY TRANSFER; EPILEPSY; GENETIC DISORDER; GLIA CELL; GLUCOSE METABOLISM; GRAY MATTER; HEPATIC ENCEPHALOPATHY; HUMAN; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; ISOTOPE LABELING; MATHEMATICAL MODEL; NERVE CELL; NEUROENERGETICS; NEUROTRANSMISSION; NONHUMAN; OXIDATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSORY STIMULATION; STROKE; SYNTHESIS; WHITE MATTER; ANIMAL; BRAIN; CITRIC ACID CYCLE; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ANIMALIA;

AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; CARBON ISOTOPES; CITRIC ACID CYCLE; ENERGY METABOLISM; GLUTAMIC ACID; GLUTAMINE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEURONS; NEUROTRANSMITTER AGENTS;

EID: 80052830781     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1772     Document Type: Review

References (153)

1. Shephard GM. The Synaptic Organization of the Brain. Oxford University Press, Oxford; 1994.
2. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron, 1996; 16(3): 675-686.
3. Bergles DE, Diamond JS, Jahr CE. Clearance of glutamate inside the synapse and beyond. Curr. Opin. Neurobiol. 1999; 9(3): 293-298.
4. Hertz L, Peng L, Dienel GA. Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J. Cereb. Blood Flow Metab. 2007; 27(2): 219-249.
5. 13C] glucose infusion. J. Neurochem. 2001; 76(4): 975-989.
6. Yu AC, Drejer J, Hertz L, Schousboe A. Pyruvate carboxylase activity in primary cultures of astrocytes and neurons. J. Neurochem. 1983; 41(5): 1484-1487.
7. Rothman DL, Behar KL, Hyder F, Shulman RG. Invivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function. Annu. Rev. Physiol. 2003; 65: 401-427.
8. Mason GF, Rothman DL. Graded image segmentation of brain tissue in the presence of inhomogeneous radio frequency fields. Magn. Reson. Imaging, 2002; 20(5): 431-436.
9. 13C-NMR. J. Cereb. Blood Flow Metab. 2005; 25(11): 1418-1423.
10. 31P MRS for measuring brain ATP synthesis. Proc. Natl. Acad. Sci. USA, 2009; 106(10): 3988-3993.
11. Hyder F, Patel AB, Gjedde A, Rothman DL, Behar KL, Shulman RG. Neuronal-glial glucose oxidation and glutamatergic-GABAergic function. J. Cereb. Blood Flow Metab. 2006; 26(7): 865-877.
12. Van den Berg CJ, Krzalić L, Mela P, Waelsch H. Compartmentation of glutamate metabolism in brain. Evidence for the existence of two different tricarboxylic acid cycles in brain. Biochem. J. 1969; 113(2): 281-290.
13. Hertz L. Functional interactions between neurons and astrocytes I. Turnover and metabolism of putative amino acid transmitters. Prog. Neurobiol. 1979; 13(3): 277-323.
14. Maycox PR, Hell JW, Jahn R. Amino acid neurotransmission: spotlight on synaptic vesicles. Trends Neurosci. 1990; 13(3): 83-87.
15. Nicholls D, Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol. Sci. 1990; 11(11): 462-468.
16. 13C]glucose. J. Neurochem. 1994; 63(4): 1377-1385.
17. Cooper AJ, Plum F. Biochemistry and physiology of brain ammonia. Physiol. Rev. 1987; 67(2): 440-519.
18. 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling. Proc. Natl. Acad. Sci. USA, 1997; 94(6): 2699-2704.
19. Lieth E, LaNoue KF, Berkich DA, Xu B, Ratz M, Taylor C, Hutson SM. Nitrogen shuttling between neurons and glial cells during glutamate synthesis. J. Neurochem. 2001; 76(6): 1712-1723.
20. Oz G, Berkich DA, Henry P-G, Xu Y, LaNoue K, Hutson SM, Gruetter R. Neuroglial metabolism in the awake rat brain: CO2 fixation increases with brain activity. J. Neurosci. 2004; 24(50): 11273-11279.
21. 15N-NMR spectroscopy studies of ammonia transport and glutamine synthesis in the hyperammonemic rat brain. Dev. Neurosci. 1998; 20(4-5): 434-443.
22. Patel AB, de Graaf RA, Mason GF, Rothman DL, Shulman RG, Behar KL. The contribution of GABA to glutamate/glutamine cycling and energy metabolism in the rat cortex invivo. Proc. Natl. Acad. Sci. USA, 2005; 102(15): 5588-5593.
23. 13C enrichment of extracellular neurotransmitter glutamate in rat brain - combined mass spectrometry and NMR studies of neurotransmitter turnover and uptake into glia invivo. Cell Mol. Biol. (Noisy-le-grand), 2003; 49(5): 819-836.
24. Gruetter R, Seaquist ER, Ugurbil K. A mathematical model of compartmentalized neurotransmitter metabolism in the human brain. Am. J. Physiol. Endocrinol. Metab. 2001; 281(1): E100-E112.
25. 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J. Neurosci. 2002; 22(5): 1523-1531.
26. 13C] glucose. J. Neurochem. 2007; 100(1): 73-86.
27. 13C NMR. Proc. Natl. Acad. Sci. USA, 1999; 96(14): 8235-8240.
28. Siesjo BK. Brain Energy Metabolism. Wiley, Chichester, New York; 1978.
29. Sibson NR, Dhankhar A, Mason GF, Rothman DL, Behar KL, Shulman RG. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc. Natl. Acad. Sci. USA, 1998; 95(1): 316-321.
30. Magistretti PJ, Pellerin L, Rothman DL, Shulman RG. Energy on demand. Science, 1999; 283(5401): 496-497.
31. Shulman RG, Hyder F, Rothman DL. Cerebral energetics and the glycogen shunt: neurochemical basis of functional imaging. Proc. Natl. Acad. Sci. USA, 2001; 98(11): 6417-6422.
32. Jolivet R, Magistretti PJ, Weber B. Deciphering neuron-glia compartmentalization in cortical energy metabolism. Front Neuroenergetics, 2009; 1: 4.
33. Occhipinti R, Somersalo E, Calvetti D. Astrocytes as the glucose shunt for glutamatergic neurons at high activity: an insilico study. J. Neurophysiol. 2009; 101(5): 2528-2538.
34. Strelnikov K. Neuroimaging and neuroenergetics: brain activations as information-driven reorganization of energy flows. Brain Cogn. 2010; 72(3): 449-456.
35. Attwell D, Laughlin SB. An energy budget for signaling in the grey matter of the brain. J. Cereb. Blood Flow Metab. 2001; 21(10): 1133-1145.
36. Chowdhury GMI, Patel AB, Mason GF, Rothman DL, Behar KL. Glutamatergic and GABAergic neurotransmitter cycling and energy metabolism in rat cerebral cortex during postnatal development. J. Cereb. Blood Flow Metab. 2007; 27(12): 1895-1907.
37. Hassel B, Bachelard H, Jones P, Fonnum F, Sonnewald U. Trafficking of amino acids between neurons and glia invivo. Effects of inhibition of glial metabolism by fluoroacetate. J. Cereb. Blood Flow Metab. 1997; 17(11): 1230-1238.
38. Patel AB, Chowdhury GMI, de Graaf RA, Rothman DL, Shulman RG, Behar KL. Cerebral pyruvate carboxylase flux is unaltered during bicuculline-seizures. J. Neurosci. Res. 2005; 79(1-2): 128-138.
39. Serres S, Raffard G, Franconi J-M, Merle M. Close coupling between astrocytic and neuronal metabolisms to fulfill anaplerotic and energy needs in the rat brain. J. Cereb. Blood Flow Metab. 2008; 28(4): 712-724.
40. 13C]-NMR. J. Cereb. Blood Flow Metab. 2010; 30(6): 1200-1213.
41. Boumezbeur F, Mason GF, de Graaf RA, Behar KL, Cline GW, Shulman GI, Rothman DL, Petersen KF. Altered brain mitochondrial metabolism in healthy aging as assessed by invivo magnetic resonance spectroscopy. J. Cereb. Blood Flow Metab. 2010; 30(1): 211-221.
42. Maciejewski PK, Rothman DL. Proposed cycles for functional glutamate trafficking in synaptic neurotransmission. Neurochem. Int. 2008; 52(4-5): 809-825.
43. DiNuzzo M, Mangia S, Maraviglia B, Giove F. Changes in glucose uptake rather than lactate shuttle take center stage in subserving neuroenergetics: evidence from mathematical modeling. J. Cereb. Blood Flow Metab. 2010; 30(3): 586-602.
44. Shestov AA, Valette J, Uǧurbil K, Henry P-G. On the reliability of (13)C metabolic modeling with two-compartment neuronal-glial models. J. Neurosci. Res. 2007; 85(15): 3294-3303.
45. Mason GF, Gruetter R, Rothman DL, Behar KL, Shulman RG, Novotny EJ. Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J. Cereb. Blood Flow Metab. 1995; 15(1): 12-25.
46. 13C magnetization transfer spectroscopy. J. Cereb. Blood Flow Metab. 2009; 29(4): 661-669.
47. Shen J, Rothman D, Behar K, Xu S. Determination of the glutamate-glutamine cycling flux using two-compartment dynamic metabolic modeling is sensitive to astroglial dilution. J. Cereb. Blood Flow Metab. 2008; 29: 108-118.
48. McKenna MC. The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain. J. Neurosci. Res. 2007; 85(15): 3347-3358.
49. 13C]glucose. Magn. Reson. Med. 1986; 3(6): 911-920.
50. 13C-edited NMR spectroscopy. J. Cereb. Blood Flow Metab. 1990; 10(2): 170-179.
51. 13C-decouple spectroscopic measurements of lactate and glutamate in the rat brain invivo. Proc. Natl. Acad. Sci. USA, 1985; 82(6): 1633-1637.
52. Gruetter R. Automatic, localized invivo adjustment of all first- and second-order shim coils. Magn. Reson. Med. 1993; 29(6): 804-811.
53. 13C NMR for the assessment of human brain glucose metabolism invivo. Biochemistry, 1991; 30(26): 6362-6366.
54. 13C NMR spectroscopy. Proc. Natl. Acad. Sci. USA, 1992; 89(3): 1109-1112.
55. 13C]glutamate turnover in human brain. Proc. Natl. Acad. Sci. USA, 1992; 89(20): 9603-9606.
56. 13C] magnetic resonance spectroscopy at 4.1T. J. Cereb. Blood Flow Metab. 1999; 19(11): 1179-1188.
57. Pan JW, Stein DT, Telang F, Lee JH, Shen J, Brown P, Cline G, Mason GF, Shulman GI, Rothman DL, Hetherington HP. Spectroscopic imaging of glutamate C4 turnover in human brain. Magn. Reson. Med. 2000; 44(5): 673-679.
58. 13C-NMR of glutamate metabolism in the human brain: initial results at 4 tesla. Dev. Neurosci. 1998; 20(4-5): 380-388.
59. 13C] NMR spectroscopy: cerebral energetics and glutamatergic/GABAergic neurotransmission. J. Neurochem. 2010; 112(1): 24-33.
60. Shulman RG, Rothman DL. Interpreting functional imaging studies in terms of neurotransmitter cycling. Proc. Natl. Acad. Sci. USA, 1998; 95(20): 11993-11998.
61. Raichle ME. A paradigm shift in functional brain imaging. J. Neurosci. 2009; 29(41): 12729-12734.
62. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF. Brain metabolism during fasting. J. Clin. Invest. 1967; 46(10): 1589-1595.
63. van Hall G, Strømstad M, Rasmussen P, Jans O, Zaar M, Gam C, Quistorff B, Secher NH, Nielsen HB. Blood lactate is an important energy source for the human brain. J. Cereb. Blood Flow Metab. 2009; 29(6): 1121-1129.
64. Smith D, Pernet A, Hallett WA, Bingham E, Marsden PK, Amiel SA. Lactate: a preferred fuel for human brain metabolism invivo. J. Cereb. Blood Flow Metab. 2003; 23(6): 658-664.
65. 1H NMR studies of glucose transport in the human brain. J. Cereb. Blood Flow Metab. 1996; 16(3): 427-438.
66. Blomqvist G, Gjedde A, Gutniak M, Grill V, Widén L, Stone-Elander S, Hellstrand E. Facilitated transport of glucose from blood to brain in man and the effect of moderate hypoglycaemia on cerebral glucose utilization. Eur. J. Nucl. Med. 1991; 18(10): 834-837.
67. 18F]-2-fluoro-2-deoxy-D-glucose. J. Cereb. Blood Flow Metab. 1984; 4(2): 212-223.
68. de Graaf RA, Pan JW, Telang F, Lee JH, Brown P, Novotny EJ, Hetherington HP, Rothman DL. Differentiation of glucose transport in human brain gray and white matter. J. Cereb. Blood Flow Metab. 2001; 21(5): 483-492.
69. Gruetter R, Ugurbil K, Seaquist ER. Steady-state cerebral glucose concentrations and transport in the human brain. J. Neurochem. 1998; 70(1): 397-408.
70. Simpson IA, Carruthers A, Vannucci SJ. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J. Cereb. Blood Flow Metab. 2007; 27(11): 1766-1791.
71. 13C-n.m.r. spectroscopy. A technique for investigating metabolic compartmentation in the brain. Biochem. J. 1990; 266(1): 133-139.
72. 13C NMR. J. Biol. Chem. 1990; 265(22): 12916-12926.
73. 1H NMR spectroscopy. NMR Biomed. 1989; 2(5-6): 274-277.
74. Waniewski RA, Martin DL. Preferential utilization of acetate by astrocytes is attributable to transport. J. Neurosci. 1998; 18(14): 5225-5233.
75. Blüml S, Moreno-Torres A, Shic F, Nguy C-H, Ross BD. Tricarboxylic acid cycle of glia in the invivo human brain. NMR Biomed. 2002; 15(1): 1-5.
76. Mason GF, Petersen KF, Lebon V, Rothman DL, Shulman GI. Increased brain monocarboxylic acid transport and utilization in type 1 diabetes. Diabetes, 2006; 55(4): 929-934.
77. 13C2]-beta-Hydroxybutyrate metabolism in human brain. J. Cereb. Blood Flow Metab. 2002; 22(7): 890-898.
78. 13C nuclear magnetic resonance spectroscopy. J. Neurosci. 2010; 30(42): 13983-13991.
79. de Graaf RA. Invivo NMR Spectroscopy. Principles and Techniques: Wiley, Chichester, England; 2007.
80. Fox PT, Raichle ME, Mintun MA, Dence C. Nonoxidative glucose consumption during focal physiologic neural activity. Science, 1988; 241(4864): 462-464.
81. Dienel GA, Hertz L. Glucose and lactate metabolism during brain activation. J. Neurosci. Res. 2001; 66(5): 824-838.
82. 1H NMR spectroscopy in the human visual cortex. J. Cereb. Blood Flow Metab. 2007; 27(5): 1055-1063.
83. 1H NMR in human visual cortex during physiologic stimulation. Proc. Natl. Acad. Sci. USA, 1991; 88(13): 5829-5831.
84. Chen W, Zhu XH, Gruetter R, Seaquist ER, Adriany G, Ugurbil K. Study of tricarboxylic acid cycle flux changes in human visual cortex during hemifield visual stimulation using (1)H-[(13)C] MRS and fMRI. Magn. Reson. Med. 2001; 45(3): 349-355.
85. Hoge RD, Atkinson J, Gill B, Crelier GR, Marrett S, Pike GB. Linear coupling between cerebral blood flow and oxygen consumption in activated human cortex. Proc. Natl. Acad. Sci. USA, 1999; 96(16): 9403-9408.
86. Kim SG, Rostrup E, Larsson HB, Ogawa S, Paulson OB. Determination of relative CMRO2 from CBF and BOLD changes: significant increase of oxygen consumption rate during visual stimulation. Magn. Reson. Med. 1999; 41(6): 1152-1161.
87. Marrett S, Gjedde A. Changes of blood flow and oxygen consumption in visual cortex of living humans. Adv. Exp. Med. Biol. 1997; 413: 205-208.
88. 1H magnetic resonance spectroscopy, in healthy aging. Neurobiol. Aging, 2009; 30(3): 353-363.
89. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch. Gen. Psychiatry, 2004; 61(5): 450-458.
90. Sanacora G, Gueorguieva R, Epperson CN, Wu Y-T, Appel M, Rothman DL, Krystal JH, Mason GF. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch. Gen. Psychiatry, 2004; 61(7): 705-713.
91. 1H-MRS at 3Tesla. Invest. Radiol. 2003; 38(7): 403-408.
92. Epperson CN, Haga K, Mason GF, Sellers E, Gueorguieva R, Zhang W, Weiss E, Rothman DL, Krystal JH. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch. Gen. Psychiatry, 2002; 59(9): 851-858.
93. 1H-magnetic resonance spectroscopy. Arch. Gen. Psychiatry, 2001; 58(6): 556-561.
94. Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry, 2007; 64(2): 193-200.
95. Kuzniecky R, Ho S, Pan J, Martin R, Gilliam F, Faught E, Hetherington H. Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology, 2002; 58(3): 368-372.
96. Novotny EJ, Hyder F, Shevell M, Rothman DL. GABA changes with vigabatrin in the developing human brain. Epilepsia, 1999; 40(4): 462-466.
97. Petroff OA, Mattson RH, Rothman DL. Proton MRS: GABA and glutamate. Adv. Neurol. 2000; 83: 261-271.
98. Novotny EJ, Fulbright RK, Pearl PL, Gibson KM, Rothman DL. Magnetic resonance spectroscopy of neurotransmitters in human brain. Ann. Neurol. 2003; 54 (Suppl 6): S25-S31.
99. Ross BD, Jacobson S, Villamil F, Korula J, Kreis R, Ernst T, Shonk T, Moats RA. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology, 1994; 193(2): 457-463.
100. Martin WRW. MR spectroscopy in neurodegenerative disease. Mol. Imaging Biol. 2007; 9(4): 196-203.
101. 13C MRS invivo. NMR Biomed. 2003; 16(6-7): 358-369.
102. 13C ethanol in rabbit brain invivo: a sensitivity comparison. Magn. Reson. Med. 1990; 16(3): 431-443.
103. 13C]glucose infusion. Magn. Reson. Med. 1991; 21(2): 302-307.
104. Petroff OA, Graham GD, Blamire AM, al-Rayess M, Rothman DL, Fayad PB, Brass LM, Shulman RG, Prichard JW. Spectroscopic imaging of stroke in humans: histopathology correlates of spectral changes. Neurology, 1992; 42(7): 1349-1354.
105. Terpstra M, Gruetter R, High WB, Mescher M, DelaBarre L, Merkle H, Garwood M. Lactate turnover in rat glioma measured by invivo nuclear magnetic resonance spectroscopy. Cancer Res. 1998; 58(22): 5083-5088.
106. 13C-1-enriched glucose. Magn. Reson. Imaging, 2010; 28(5): 690-697.
107. Butterworth RF. Portal-systemic encephalopathy: a disorder of neuron-astrocytic metabolic trafficking. Dev. Neurosci. 1993; 15(3-5): 313-319.
108. 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am. J. Psychiatry, 1999; 156(6): 952-954.
109. 31P nuclear magnetic resonance. J. Neurochem. 1989; 52(3): 741-749.
110. 15N heteronuclear multiple-quantum coherence-transfer NMR in severely hyperammonemic rat. J. Neurochem. 1997; 68(3): 1209-1220.
111. 31P NMR study. In: Butterworth RF, Layrargues GP (eds.). Hepatic Encephalopathy, Pathophysiology and Treatment. Humana Press: Clifton, NJ; 1989, pp. 189-200.
112. Fitzpatrick SM, Behar KL, Shulman RG. Invivo NMR spectroscopy studies of cerebral metabolism in rats after portal-caval shunting. In: Butterworth RF, Layrargues GP (eds.). Hepatic Encephalopathy, Pathophysiology and Treatment. Humana Press: Clifton, NJ; 1989, pp. 177-187.
113. 13C]glucose MRS in chronic hepatic encephalopathy in man. Magn. Reson. Med. 2001; 45(6): 981-993.
114. Gropman AL, Sailasuta N, Harris KC, Abulseoud O, Ross BD. Ornithine transcarbamylase deficiency with persistent abnormality in cerebral glutamate metabolism in adults. Radiology, 2009; 252(3): 833-841.
115. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 2006; 443(7113): 787-795.
116. Kalpouzos G, Chételat G, Baron J-C, Landeau B, Mevel K, Godeau C, Barré L, Constans J-M, Viader F, Eustache F, Desgranges B. Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol. Aging, 2009; 30(1): 112-124.
117. Rapoport SI. Functional brain imaging in the resting state and during activation in Alzheimer's disease. Implications for disease mechanisms involving oxidative phosphorylation. Ann. NY Acad. Sci. 1999; 893: 138-153.
118. Lin AP, Shic F, Enriquez C, Ross BD. Reduced glutamate neurotransmission in patients with Alzheimer's disease - an invivo (13)C magnetic resonance spectroscopy study. MAGMA, 2003; 16(1): 29-42.
119. Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N. Engl. J. Med. 2004; 350(22): 2272-2279.
120. Cryer PE. Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM. Diabetes, 1994; 43(11): 1378-1389.
121. Oz G, Kumar A, Rao JP, Kodl CT, Chow L, Eberly LE, Seaquist ER. Human brain glycogen metabolism during and after hypoglycemia. Diabetes, 2009; 58(9): 1978-1985.
122. Pan JW, Williamson A, Cavus I, Hetherington HP, Zaveri H, Petroff OAC, Spencer DD. Neurometabolism in human epilepsy. Epilepsia, 2008; 49 (Suppl 3): 31-41.
123. Cavus I, Kasoff WS, Cassaday MP, Jacob R, Gueorguieva R, Sherwin RS, Krystal JH, Spencer DD, Abi-Saab WM. Extracellular metabolites in the cortex and hippocampus of epileptic patients. Ann. Neurol. 2005; 57(2): 226-235.
124. Petroff OAC, Errante LD, Rothman DL, Kim JH, Spencer DD. Glutamate-glutamine cycling in the epileptic human hippocampus. Epilepsia, 2002; 43(7): 703-710.
125. Eid T, Thomas MJ, Spencer DD, Rundén-Pran E, Lai JCK, Malthankar GV, Kim JH, Danbolt NC, Ottersen OP, de Lanerolle NC. Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy. Lancet, 2004; 363(9402): 28-37.
126. Blüml S, Moreno A, Hwang JH, Ross BD. 1-(13)C glucose magnetic resonance spectroscopy of pediatric and adult brain disorders. NMR Biomed. 2001; 14(1): 19-32.
127. de Graaf RA, Mason GF, Patel AB, Rothman DL, Behar KL. Regional glucose metabolism and glutamatergic neurotransmission in rat brain invivo. Proc. Natl. Acad. Sci. USA, 2004; 101(34): 12700-12705.
128. 13C] D-glucose. Magn. Reson. Med. 1999; 41(6): 1077-1083.
129. 15N labeled choline in rats. Phys. Chem. Chem. Phys. 2010; 12(22): 5818-5823.
130. 13C spectroscopy in the rat brain using hyperpolarized [1-(13)C]pyruvate and [2-(13)C]pyruvate. J. Magn. Reson. 2010; 206(2): 210-218.
131. Bhattacharya P, Chekmenev EY, Perman WH, Harris KC, Lin AP, Norton VA, Tan CT, Ross BD, Weitekamp DP. Towards hyperpolarized (13)C-succinate imaging of brain cancer. J. Magn. Reson. 2007; 186(1): 150-155.
132. 1H spectroscopic imaging. Magn. Reson. Med. 2006; 56(1): 26-33.
133. Juchem C, Nixon TW, McIntyre S, Rothman DL, de Graaf RA. Magnetic field homogenization of the human prefrontal cortex with a set of localized electrical coils. Magn. Reson. Med. 2010; 63(1): 171-180.
134. 1H magnetic resonance spectroscopy and multislice magnetic resonance spectroscopic imaging of the human brain. Magn. Reson. Med. 2007; 57(3): 587-591.
135. de Graaf RA. Theoretical and experimental evaluation of broadband decoupling techniques for invivo nuclear magnetic resonance spectroscopy. Magn. Reson. Med. 2005; 53(6): 1297-1306.
136. Collins CM, Liu W, Wang J, Gruetter R, Vaughan JT, Ugurbil K, Smith MB. Temperature and SAR calculations for a human head within volume and surface coils at 64 and 300MHz. J. Magn. Reson. Imaging, 2004; 19(5): 650-656.
137. Adriany G, Gruetter R. A half-volume coil for efficient proton decoupling in humans at 4tesla. J. Magn. Reson. 1997; 125(1): 178-184.
138. 13C MR spectroscopy of the human brain at 3Tesla. Magn. Reson. Med. 2006; 55(2): 271-278.
139. 13C MRS using very low RF power for proton decoupling. Magn. Reson. Med. 2007; 57(2): 265-271.
140. Sailasuta N, Abulseoud O, Harris KC, Ross BD. Glial dysfunction in abstinent methamphetamine abusers. J. Cereb. Blood Flow Metab. 2010; 30(5): 950-960.
141. 13C]glucose infusion and low-power stochastic decoupling. Magn. Reson. Med. 2009; 62(3): 565-573.
142. 13C MRS of occipital and frontal lobes at 3T using a volume coil for stochastic proton decoupling. NMR Biomed. 2010; 23(8): 977-985.
143. Mason GF, Rothman DL. Basic principles of metabolic modeling of NMR (13)C isotopic turnover to determine rates of brain metabolism invivo. Metab. Eng. 2004; 6(1): 75-84.
144. Moreno A, Blüml S, Hwang JH, Ross BD. Alternative 1-(13)C glucose infusion protocols for clinical (13)C MRS examinations of the brain. Magn. Reson. Med. 2001; 46(1): 39-48.
145. Mason GF, Falk Petersen K, de Graaf RA, Kanamatsu T, Otsuki T, Shulman GI, Rothman DL. A comparison of (13)C NMR measurements of the rates of glutamine synthesis and the tricarboxylic acid cycle during oral and intravenous administration of [1-(13)C]glucose. Brain Res. Brain Res. Protoc. 2003; 10(3): 181-190.
146. 13C magnetic resonance spectroscopy at 3T of human brain glucose metabolism under euglycemic and hypoglycemic conditions. J. Neurosci. Methods, 2010; 186(1): 68-71.
147. Sailasuta N, Tran TT, Harris KC, Ross BD. Swift Acetate Glial Assay (SAGA): an accelerated human (13)C MRS brain exam for clinical diagnostic use. J. Magn. Reson. 2010; 207(2): 352-355.
148. Chhina N, Kuestermann E, Halliday J, Simpson LJ, Macdonald IA, Bachelard HS, Morris PG. Measurement of human tricarboxylic acid cycle rates during visual activation by (13)C magnetic resonance spectroscopy. J. Neurosci. Res. 2001; 66(5): 737-746.
149. Henry P-G, Criego AB, Kumar A, Seaquist ER. Measurement of cerebral oxidative glucose consumption in patients with type 1 diabetes mellitus and hypoglycemia unawareness using (13)C nuclear magnetic resonance spectroscopy. Metab. Clin. Exp. 2010; 59(1): 100-106.
150. Patel AB, de Graaf RA, Mason GF, Kanamatsu T, Rothman DL, Shulman RG, Behar KL. Glutamatergic neurotransmission and neuronal glucose oxidation are coupled during intense neuronal activation. J. Cereb. Blood Flow Metab. 2004; 24(9): 972-985.
151. Choi I-Y, Lei H, Gruetter R. Effect of deep pentobarbital anesthesia on neurotransmitter metabolism invivo: on the correlation of total glucose consumption with glutamatergic action. J. Cereb. Blood Flow Metab. 2002; 22(11): 1343-1351.
152. Wang J, Jiang L, Jiang Y, Ma X, Chowdhury GMI, Mason GF. Regional metabolite levels and turnover in the awake rat brain under the influence of nicotine. J. Neurochem. 2010; 113(6): 1447-1458.
153. Yang J, Shen J. Invivo evidence for reduced cortical glutamate-glutamine cycling in rats treated with the antidepressant/antipanic drug phenelzine. Neuroscience, 2005; 135(3): 927-937.